S Immo AG

Q2 in the books – SO & delisting expected for H2; chg.

Philipp Sennewald30 Aug 2024 05:22

Topic: S IMMO released its H1 results on Wednesday evening, showing strong top line growth as well as improved operating profitability.

Q2 sales increased by 15% yoy to € 186m (eNuW: € 181m), which was mainly driven by increased rental income of € 112m (+19.2% yoy) following several major acquisitions in Austria and the Czech Republic. Moreover, the hotel segment grew revenues by 7.7% yoy to € 33.8m.

Against this backdrop, FFO I increased by 47% yoy to € 1.04 per share, also implying an FFO margin improvement of 9pp driven by operating leverage on the G&A level. The EPRA NTA remained stable at € 24.86 per share.

Disposal program on track. In H1, S IMMO continued the disposal of its properties in Germany. The company aims to leave the German market entirely in order to invest the freed funds into higher yielding properties in the CEE region. As of H1, the company reduced its portfolio in Germany to € 300m, which compares to € 1.25bn 18 months ago. During this time, the average gross initial yield of the total portfolio increased by 1.1pp to 6.9%, which should serve as a proof of concept for the shift in strategy. Management aims for a disposal of the remaining properties in due course (eNuW: until H1 ‘25e).

Squeeze-out and delisting looming. S IMMO announced that the Extraordinary General Meeting to resolve the squeeze-out is expected to take place in autumn, likely in October/November. Before this, The cash settlement will be determined on the basis of an external expert opinion. Afterward, the resolution must be entered into the commercial register, whereupon a two-months period for the cash settlement begins. At the same time, the Vienna Stock Exchange is seen to initiate the delisting of the shares, which we expect to happen already in the course of Q4.

Hence, the stock remains a HOLD. Yet, we increase our PT to € 24 (old: € 19) in light of the looming squeeze-out. The new PT is orientated to the current BV/ps of € 23.63 and the NTA/ps of € 24.86.

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.